Advisor/Sr. Advisor - Macrocycles Chemical Biology at Eli Lilly and Company

Pasadena, California, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical Research, BiotechnologyIndustries

Skills

Key technologies and capabilities for this role

Peptide ChemistryMacrocycle ChemistryMolecular EngineeringLead OptimizationOral Drug DeliveryChemical BiologyMolecule DesignConjugationPhase 1bLead Display Screening

Questions & Answers

Common questions about this position

What is the location or work arrangement for this position?

This information is not specified in the job description.

What salary or compensation does this role offer?

This information is not specified in the job description.

What key skills and experience are required for this role?

Candidates need a proven track record of leading scientific rationale, planning, and execution, experience in similar roles, and the ability to independently lead projects, with expertise in chemical biology, peptides, and macrocycles.

What is the team culture like at Protomer?

The Protomer team is highly integrated, agile, and collaborative, focusing on chemical biology, molecular switches, and oral peptidic macrocycles, with emphasis on mentoring junior scientists and cross-functional relationships across therapeutic areas.

What makes a strong candidate for this Advisor/Sr. Advisor position?

A strong candidate has demonstrated success in similar roles with a proven track record of leading scientific rationale, planning, and execution to make medicines, plus the ability to manage teams, develop strategy, and lead projects independently.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free